My guest today is Bobby Faison, Executive Director, Medical Affairs with Paratek Pharmaceuticals. Bobby discusses why and how to build a “Community” MSL team.
Bobby shares…
👉 What is a “Community” MSL
👉 How a “Community” MSL is different from a traditional, therapeutic MSL
👉 What the relationship with commercial looks like
👉 What the expectations are for “Community” MSLs in regard to metrics and KPIs
👉 Advice for organizations looking to implement this model
👉 Why the Community MSL role is a great pathway for Aspiring MSLs
The podcast is available through the links below:
️ ️ 〰️ Spotify: https://lnkd.in/dRrSEyn
️ ️ 〰️ Apple: https://lnkd.in/egSthAz
️ ️ 〰️ Stitcher: https://lnkd.in/eqB-2wb
📣 Now on YouTube 📣
Please subscribe: https://www.youtube.com/channel/UCS7XTUuk1XF5Tm5InADY6cA
📣 Now on Instagram 📣
Please subscribe:
https://www.instagram.com/msl_talk_podcast/
MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversation and medical affairs discussions.
#msl #medicalaffairs #medicalscienceliaison #MSLTalk #pharmaceutical
(0:00) Introduction of Bobby Faizan and podcast overview
(1:13) Importance and model of building a community MSL team
(5:04) Tools for KOL mapping and engagement strategies for community MSLs
(8:12) Sponsor: H1
(10:31) Hiring and qualifications for community MSL teams
(14:33) Entry-level opportunities and access challenges for community MSLs
(17:52) Budget and commercial team relationships
(20:59) Pros and cons of deploying a community MSL team
(22:36) Territory management and travel for community MSLs
(24:28) Metrics and company suitability for the community MSL model
(26:54) Role of community MSLs in informing formularies and clinical pathways
(29:09) Customer segmentation for field medical teams
(30:08) Career advancement advice for MSLs
(31:12) Closing remarks and subscription reminder